Medicenna takes on deadly brain cancer in clinical trial
The immunotherapy firm is conducting a Phase III trial centered on an innovative approach to treating recurrent glioblastoma, an aggressive brain cancer.
Archives for July 8, 2021
CRO Parexel to be acquired by Goldman Sachs in $8.5b deal
The global contract research organization has announced it will be purchased by Goldman Sachs Asset Management and EQT Private Equity.
People on the Move: July 2021
This month’s news on hires, promotions, acquisitions, and expansions includes items about Javara, Elligo, Lonza, Yourway, Medable, and other notable firms.